SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-042995
Filing Date
2019-11-12
Accepted
2019-11-12 16:49:15
Documents
59
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q umrx-10q_20190930.htm 10-Q 2490234
2 EX-10.2 umrx-ex102_13.htm EX-10.2 73371
3 EX-10.3 umrx-ex103_52.htm EX-10.3 41854
4 EX-31.1 umrx-ex311_10.htm EX-31.1 12775
5 EX-31.2 umrx-ex312_7.htm EX-31.2 12755
6 EX-32.1 umrx-ex321_8.htm EX-32.1 9690
7 EX-32.2 umrx-ex322_9.htm EX-32.2 9775
  Complete submission text file 0001564590-19-042995.txt   6268021

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT umrx-20190930.xml EX-101.INS 1022337
9 XBRL TAXONOMY EXTENSION SCHEMA umrx-20190930.xsd EX-101.SCH 38109
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE umrx-20190930_cal.xml EX-101.CAL 50620
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE umrx-20190930_def.xml EX-101.DEF 106622
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE umrx-20190930_lab.xml EX-101.LAB 327456
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE umrx-20190930_pre.xml EX-101.PRE 238383
Mailing Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140
Business Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140 617-945-5576
Unum Therapeutics Inc. (Filer) CIK: 0001622229 (see all company filings)

IRS No.: 465308248 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38443 | Film No.: 191210374
SIC: 2834 Pharmaceutical Preparations